Watch Now on PHEN TV
Immuno-oncology is transforming how doctors treat prostate cancer — and giving men living with the disease new hope.
In this PHEN TV program, experts explain how immunotherapies work by helping your body’s immune system find and destroy prostate cancer cells.
▶ Watch the full video on PHEN TV
A New Frontier in Prostate Cancer Treatment
For decades, prostate cancer care focused on surgery, radiation, and hormone therapy.
Now, immuno-oncology introduces a powerful new approach — using the immune system itself to attack tumors.
Emerging treatments, like T-cell engagers and bispecific antibodies, connect immune cells directly to prostate cancer cells, helping the body fight back more effectively.
Precision Medicine and Biomarkers
Doctors are now using biomarkers and advanced imaging to guide treatment choices.
These tests identify which men may benefit most from immune-based therapy and help monitor how well treatment is working over time.
This personalized approach marks an important step forward in prostate cancer care.
Combinations That Boost Results
Immuno-oncology is also being studied in combination with other treatments, such as:
- Radioligand therapy
- Hormone therapy
- PARP inhibitors
- Checkpoint inhibitors
By combining therapies, doctors hope to create longer-lasting responses and better quality of life for men living with prostate cancer.
Questions to Ask Your Doctor
If you’re living with prostate cancer, ask your healthcare team:
- Am I a candidate for immunotherapy?
- What biomarkers should be tested?
- How does immunotherapy fit into my current treatment plan?
- Are there clinical trials that might be right for me?
Looking Ahead
Immuno-oncology may be the next major step in care for prostate cancer survivors.
By empowering the immune system, these new treatments could help men live longer, healthier lives with fewer side effects.
Watch the full video to learn more:
https://phentv.com/aiovg_videos/immuno-oncology-the-next-step-in-care-for-men-living-with-prostate-cancer/
